GMP Antibodies for T Cell Activation

Add flexibility to your immune cell therapy manufacturing workflow with new GMP anti-CD3 and anti-CD28 antibodies. Vary the phenotypic profiles of your immune cells by optimizing CD3/CD28 antibody ratios for fine-tuned cell activation. These soluble antibodies allow for maximum flexibility to optimize protocols to your specific platform and cells.

Improve the phenotypic profiles of your T cells and reduce exhaustion by optimizing CD3/CD28 antibody ratios for fine-tuned cell activation. New GMP recombinant CD3 and CD28 antibodies allow for maximum flexibility to optimize activation protocols for your platform and cells.